Estimated Risk Reduction to Packaged Food Reactions by Epicutaneous Immunotherapy (EPIT) for Peanut Allergy

Peanut allergy is a generally persistent, sometimes life-threatening food allergy that is increasing in prevalence in Western countries.1 There are no FDA-approved therapies for treatment of peanut allergy, and patients must strictly avoid peanut and be prepared to use rescue medication upon symptoms due to unintentional peanut ingestion.1 However, complete avoidance of peanut is difficult at least in part due to its widespread use as a food ingredient in packaged foods and in restaurant or catered meals.

Source: Annals of Allergy, Asthma and Immunology - August 19, 2019 Category: Allergy & Immunology Authors: Benjamin C. Remington, Tanja Krone, Edwin H. Kim, J. Andrew Bird, Todd D. Green, Gideon Lack, David M. Fleischer, Stef J. Koppelman Source Type: research